Abnormalities in microbiota/butyrate/FFAR3 signaling in aging gut impair brain function is a research paper published in JCI Insight (2024). On theSindex it has a DataRank of 0. It has been cited 62 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NIA NIH HHS
Grant: R56 AG069676
NIDCR NIH HHS
Grant: R21 DE032197
National Institutes of Health
Grant: R21DE032197,U01AG076928
NIA NIH HHS
Grant: R56 AG064075
NIA NIH HHS
Grant: RF1 AG071762
NIA NIH HHS
Grant: R01 AG071762
NIA NIH HHS
Grant: R21 AG072379
National Institutes of Health
Grant: R56AG069676,R56AG064075,R01AG071762,R21AG072379
NIA NIH HHS
Grant: U01 AG076928
Florida Department of Health
Grant: 22A17
Congressionally Directed Medical Research Programs
Grant: W81XWH-18-PRARP
National Institutes of Health
Grant: 4R01AG071762-02
Microbial therapy improves gut permeability to reduce cognitive decline and Alzheimer’s disease
National Institutes of Health
Grant: 1R56AG064075-01A1
Gut microbiota-based biomarkers of Alzheimer's disease and its modulation by a ketogenic diet
National Institutes of Health
Grant: 1R21DE032197-01A1
Identification of bacterial strains for development of an oral probiotic aimed at increasing nitric oxide bioavailability
National Institutes of Health
Grant: 1R21AG072379-01
The role of gut microbiota in the efficacy of ketogenic diet to ameliorate Alzheimer's disease
National Institutes of Health
Grant: 5U01AG076928-03
Repurposing of Metormin for Older Patients with HFpEF
National Institutes of Health
Grant: 1R56AG069676-01
Metformin and Alzheimer's disease: Underlying Mechanisms that Ameliorate Progression
FWCI
10.95
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals